Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Net Margin: 2023-2025

Historic Net Margin for Inhibrx Biosciences (INBX) over the last 3 years, with Sep 2025 value amounting to 1,108.33%.

  • Inhibrx Biosciences' Net Margin was N/A to 1,108.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 1,740.39%, marking a year-over-year change of. This contributed to the annual value of 843,786.00% for FY2024, which is 85710417.00% up from last year.
  • As of Q3 2025, Inhibrx Biosciences' Net Margin stood at 1,108.33%, which was up 21.49% from 912.26% recorded in Q2 2025.
  • Over the past 5 years, Inhibrx Biosciences' Net Margin peaked at 1,610.67% during Q1 2025, and registered a low of -287,741.18% during Q2 2023.
  • In the last 3 years, Inhibrx Biosciences' Net Margin had a median value of -5,628.52% in 2023 and averaged -46,090.38%.
  • Examining YoY changes over the last 5 years, Inhibrx Biosciences' Net Margin showed a top increase of 25,308,326bps in 2024 and a maximum decrease of 4,223,648bps in 2024.
  • Inhibrx Biosciences' Net Margin (Quarterly) stood at -5,628.52% in 2023, then crashed by 4,223,648bps to -47,865.00% in 2024, then soared by 3,557,018bps to 1,108.33% in 2025.
  • Its Net Margin was 1,108.33% in Q3 2025, compared to 912.26% in Q2 2025 and 1,610.67% in Q1 2025.